| 865 | Humans |
| 485 | Female |
| 407 | Male |
| 314 | Middle Aged |
| 277 | Adult |
| 232 | Aged |
| 154 | Animals |
| 129 | Treatment Outcome |
| 128 | Genetic Predisposition to Disease |
| 126 | Polymorphism, Single Nucleotide |
| 112 | Risk Factors |
| 106 | Adolescent |
| 100 | Genome-Wide Association Study |
| 99 | Young Adult |
| 97 | Aged, 80 and over |
| 85 | Case-Control Studies |
| 80 | Genotype |
| 77 | Mutation |
| 73 | Europe |
| 69 | Breast Neoplasms |
| 67 | Prospective Studies |
| 62 | Time Factors |
| 61 | Child |
| 59 | Prognosis |
| 54 | Follow-Up Studies |
| 51 | Cohort Studies |
| 49 | Mice |
| 49 | European Continental Ancestry Group |
| 49 | Antineoplastic Combined Chemotherapy Protocols |
| 46 | Double-Blind Method |
| 43 | Phenotype |
| 42 | Genetic Variation |
| 40 | Age Factors |
| 37 | Retrospective Studies |
| 36 | Child, Preschool |
| 35 | Practice Guidelines as Topic |
| 35 | Ovarian Neoplasms |
| 35 | Disease-Free Survival |
| 34 | Phylogeny |
| 34 | Consensus |
| 33 | Risk Assessment |
| 33 | Infant |
| 33 | Alleles |
| 31 | Survival Rate |
| 31 | Genetic Association Studies |
| 30 | Severity of Illness Index |
| 30 | Reproducibility of Results |
| 30 | Neoplasm Staging |
| 30 | Antineoplastic Agents |
| 29 | Signal Transduction |
| 29 | Risk |
| 29 | Genetic Loci |
| 28 | Proportional Hazards Models |
| 28 | Disease Progression |
| 26 | Drug Therapy, Combination |
| 26 | Clinical Trials as Topic |
| 26 | Biomarkers |
| 25 | Global Health |
| 25 | Chromosome Mapping |
| 24 | Survival Analysis |
| 24 | Randomized Controlled Trials as Topic |
| 24 | Body Mass Index |
| 24 | Australia |
| 23 | Surveys and Questionnaires |
| 23 | Registries |
| 23 | Quantitative Trait Loci |
| 23 | Protein Kinase Inhibitors |
| 23 | Prostatic Neoplasms |
| 23 | Odds Ratio |
| 23 | Ecosystem |
| 22 | Neoplasms |
| 22 | Melanoma |
| 22 | Incidence |
| 22 | Computational Biology |
| 22 | Biodiversity |
| 21 | Sequence Analysis, DNA |
| 21 | Molecular Sequence Data |
| 21 | Internationality |
| 21 | International Cooperation |
| 21 | Drug Administration Schedule |
| 20 | Quality of Life |
| 20 | Mice, Inbred C57BL |
| 20 | Magnetic Resonance Imaging |
| 19 | Haplotypes |
| 19 | Genome, Human |
| 19 | Gene Expression Profiling |
| 19 | Colorectal Neoplasms |
| 19 | Antibodies, Monoclonal, Humanized |
| 18 | Terminology as Topic |
| 18 | Skin Neoplasms |
| 18 | Pedigree |
| 18 | Kaplan-Meier Estimate |
| 18 | Genomics |
| 18 | Evolution, Molecular |
| 18 | Cardiovascular Diseases |
| 18 | Brain |
| 18 | Biomarkers, Tumor |
| 18 | Antiviral Agents |
| 17 | Societies, Medical |
| 17 | Pregnancy |
| 17 | Multivariate Analysis |
| 17 | Gene Expression Regulation |
| 16 | RNA, Messenger |
| 16 | Infant, Newborn |
| 16 | Gene Frequency |
| 16 | Disease Management |
| 16 | Biological Evolution |
| 16 | Algorithms |
| 15 | Recombinant Proteins |
| 15 | Predictive Value of Tests |
| 15 | Neoplasm Recurrence, Local |
| 15 | Imidazoles |
| 15 | Heterozygote |
| 15 | Hepatitis C, Chronic |
| 15 | Hematopoietic Stem Cell Transplantation |
| 14 | Recurrence |
| 14 | Polyethylene Glycols |
| 14 | Neoplasm Metastasis |
| 14 | Meta-Analysis as Topic |
| 14 | High-Throughput Nucleotide Sequencing |
| 14 | Hepacivirus |
| 14 | Diet |
| 14 | DNA Mutational Analysis |
| 14 | Cross-Sectional Studies |
| 14 | Cell Line, Tumor |
| 14 | Amino Acid Sequence |
| 13 | Stroke |
| 13 | Prevalence |
| 13 | Exome |
| 13 | Evidence-Based Medicine |
| 13 | Databases, Factual |
| 13 | Climate |
| 13 | Cell Line |
| 13 | Antibodies, Monoclonal |
| 13 | Age of Onset |
| 12 | Ribavirin |
| 12 | Respiration, Artificial |
| 12 | Research Design |
| 12 | Pyrimidines |
| 12 | Oligopeptides |
| 12 | Obesity |
| 12 | Neoplasms, Glandular and Epithelial |
| 12 | Neoplasm Grading |
| 12 | Multiple Myeloma |
| 12 | Membrane Proteins |
| 12 | Lung Neoplasms |
| 12 | Genetic Testing |
| 12 | Drug Resistance, Neoplasm |
| 12 | Dose-Response Relationship, Drug |
| 12 | Cause of Death |
| 12 | Carbon Dioxide |
| 12 | Base Sequence |
| 12 | Asian Continental Ancestry Group |
| 11 | Trees |
| 11 | Species Specificity |
| 11 | Sensitivity and Specificity |
| 11 | Receptors, Estrogen |
| 11 | Proteins |
| 11 | Nuclear Proteins |
| 11 | Neuropsychological Tests |
| 11 | Models, Molecular |
| 11 | Models, Biological |
| 11 | Germ-Line Mutation |
| 11 | Gene Expression Regulation, Neoplastic |
| 11 | DNA Methylation |
| 11 | Conservation of Natural Resources |
| 11 | Comorbidity |
| 11 | Combined Modality Therapy |
| 11 | Cells, Cultured |
| 11 | Bayes Theorem |
| 11 | BRCA1 Protein |
| 11 | Arthritis, Rheumatoid |
| 10 | Viral Load |
| 10 | United States |
| 10 | Tumor Suppressor Proteins |
| 10 | Sulfonamides |
| 10 | Software |
| 10 | Sex Factors |
| 10 | Promoter Regions, Genetic |
| 10 | Postoperative Complications |
| 10 | Mutation, Missense |
| 10 | Models, Genetic |
| 10 | Interferon-alpha |
| 10 | Intensive Care Units |
| 10 | History, Ancient |
| 10 | Genetics, Population |
| 10 | Epigenesis, Genetic |
| 10 | Computer Simulation |
| 10 | Cholesterol, LDL |
| 10 | Chemotherapy, Adjuvant |
| 10 | Bipolar Disorder |
| 10 | Asthma |
| 10 | Aging |
| 9 | Water |
| 9 | United Kingdom |
| 9 | Tomography, X-Ray Computed |
| 9 | Smoking |
| 9 | Sex Distribution |
| 9 | Repressor Proteins |
| 9 | Receptor, ErbB-2 |
| 9 | Protein Binding |
| 9 | Prosthesis Design |
| 9 | Plant Leaves |
| 9 | Models, Theoretical |
| 9 | Mice, Knockout |
| 9 | Longitudinal Studies |
| 9 | Genes, BRCA2 |
| 9 | Gene Expression |
| 9 | Forests |
| 9 | Disease Models, Animal |
| 9 | Diabetes Mellitus, Type 2 |
| 9 | Databases, Genetic |
| 9 | DNA |
| 9 | DNA-Binding Proteins |
| 9 | DNA Copy Number Variations |
| 9 | Cognition |
| 9 | Cognition Disorders |
| 9 | Cell Differentiation |
| 9 | Carbon Cycle |
| 8 | Transcription, Genetic |
| 8 | Temperature |
| 8 | Respiratory Distress Syndrome, Adult |
| 8 | Reproduction |
| 8 | Remission Induction |
| 8 | Plants |
| 8 | Photosynthesis |
| 8 | Outcome Assessment (Health Care) |
| 8 | Mortality |
| 8 | Models, Statistical |
| 8 | Mendelian Randomization Analysis |
| 8 | Logistic Models |
| 8 | Liver Cirrhosis |
| 8 | Image Processing, Computer-Assisted |
| 8 | HIV Infections |
| 8 | HEK293 Cells |
| 8 | Guidelines as Topic |
| 8 | Genes, BRCA1 |
| 8 | Flow Cytometry |
| 8 | Exons |
| 8 | Exercise |
| 8 | Enhancer Elements, Genetic |
| 8 | Diagnosis, Differential |
| 8 | Critical Care |
| 8 | Climate Change |
| 8 | Carrier Proteins |
| 8 | Brain Neoplasms |
| 8 | Blood Glucose |
| 8 | Alternative Splicing |
| 8 | Adenocarcinoma |
| 7 | Stents |
| 7 | Salvage Therapy |
| 7 | Regression Analysis |
| 7 | Rats |
| 7 | ROC Curve |
| 7 | RNA, Viral |
| 7 | Protein Conformation |
| 7 | Precision Medicine |
| 7 | Postmenopause |
| 7 | Plant Proteins |
| 7 | Paclitaxel |
| 7 | Observer Variation |
| 7 | New Zealand |
| 7 | Neoadjuvant Therapy |
| 7 | Myocardial Infarction |
| 7 | Multiple Sclerosis |
| 7 | Molecular Targeted Therapy |
| 7 | Molecular Sequence Annotation |
| 7 | Menopause |
| 7 | Liver Neoplasms |
| 7 | Injections, Subcutaneous |
| 7 | Immunotherapy |
| 7 | Immunosuppressive Agents |
| 7 | Immunohistochemistry |
| 7 | Hyperlipoproteinemia Type II |
| 7 | Hospitalization |
| 7 | Hospital Mortality |
| 7 | Homozygote |
| 7 | Heart Failure |
| 7 | Genome, Plant |
| 7 | Genetic Markers |
| 7 | Fossils |
| 7 | Forecasting |
| 7 | Feeding Behavior |
| 7 | Environmental Monitoring |
| 7 | Early Detection of Cancer |
| 7 | Doxorubicin |
| 7 | Depression |
| 7 | Datasets as Topic |
| 7 | Cost-Benefit Analysis |
| 7 | Coronary Artery Disease |
| 7 | Cooperative Behavior |
| 7 | Cluster Analysis |
| 7 | Brain Ischemia |
| 7 | Biomedical Research |
| 7 | Binding Sites |
| 7 | Anticholesteremic Agents |
| 7 | Anti-Bacterial Agents |
| 7 | Amino Acid Substitution |
| 7 | Allergens |
| 7 | Age Distribution |
| 7 | Africa |
| 7 | Administration, Oral |
| 6 | Zebrafish |
| 6 | Triazoles |
| 6 | Transplantation Conditioning |
| 6 | Transcriptome |
| 6 | Transcription Factors |
| 6 | Syndrome |
| 6 | Sequence Alignment |
| 6 | Selection, Genetic |
| 6 | Seawater |
| 6 | Schizophrenia |
| 6 | Retreatment |
| 6 | Reference Standards |
| 6 | Receptors, Cell Surface |
| 6 | Real-Time Polymerase Chain Reaction |
| 6 | Pyrroles |
| 6 | Pyridones |
| 6 | Proto-Oncogene Proteins B-raf |
| 6 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| 6 | Positron-Emission Tomography |
| 6 | Polymerase Chain Reaction |
| 6 | Phylogeography |
| 6 | Oximes |
| 6 | Oligonucleotide Array Sequence Analysis |
| 6 | Oceans and Seas |
| 6 | Occupational Exposure |
| 6 | MCF-7 Cells |
| 6 | Liver |
| 6 | Linkage Disequilibrium |
| 6 | Linear Models |
| 6 | Internet |
| 6 | Intention to Treat Analysis |
| 6 | Intellectual Disability |
| 6 | Insulin |
| 6 | Inflammation |
| 6 | Indoles |
| 6 | Hypertension |
| 6 | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| 6 | Human Migration |
| 6 | Health Services Accessibility |
| 6 | Grassland |
| 6 | Glioma |
| 6 | Germany |
| 6 | Genotyping Techniques |
| 6 | Gene Dosage |
| 6 | France |
| 6 | Forced Expiratory Volume |
| 6 | Fluorouracil |
| 6 | Extinction, Biological |
| 6 | Estrogen Receptor alpha |
| 6 | Droughts |
| 6 | Diagnostic Imaging |
| 6 | Dermatitis, Atopic |
| 6 | Continental Population Groups |
| 6 | Cisplatin |
| 6 | Chromosomes, Human, X |
| 6 | Chromosomes, Human, Pair 2 |
| 6 | Chromosome Aberrations |
| 6 | Cell Proliferation |
| 6 | Carcinoma, Squamous Cell |
| 6 | Carbon |
| 6 | Canada |
| 6 | Blotting, Western |
| 6 | Blood Pressure |
| 6 | Bevacizumab |
| 6 | Benzimidazoles |
| 6 | BRCA2 Protein |
| 6 | Atrial Fibrillation |
| 6 | Area Under Curve |
| 6 | Alzheimer Disease |
| 6 | Adiposity |
| 6 | Adaptor Proteins, Signal Transducing |
| 5 | Water Pollutants, Chemical |
| 5 | Vaccination |
| 5 | Ubiquitin-Protein Ligases |
| 5 | Trastuzumab |
| 5 | Transplantation, Homologous |
| 5 | Tomography, Optical Coherence |
| 5 | Structure-Activity Relationship |
| 5 | Stomach Neoplasms |
| 5 | Soil |
| 5 | Socioeconomic Factors |
| 5 | Sjogren's Syndrome |
| 5 | Sex Characteristics |
| 5 | Secondary Prevention |
| 5 | Seasons |
| 5 | Rhinitis, Allergic |
| 5 | Reverse Transcriptase Polymerase Chain Reaction |
| 5 | Renal Insufficiency, Chronic |
| 5 | Reference Values |
| 5 | Receptors, Progesterone |
| 5 | Receptor, Epidermal Growth Factor |
| 5 | Quinazolines |
| 5 | Pyrimidinones |
| 5 | Pyrazoles |
| 5 | Pulmonary Disease, Chronic Obstructive |
| 5 | Protein Isoforms |
| 5 | Population Surveillance |
| 5 | Population Dynamics |
| 5 | Platelet Aggregation Inhibitors |
| 5 | Percutaneous Coronary Intervention |
| 5 | Patient Selection |
| 5 | Papillomavirus Infections |
| 5 | Pancreatic Neoplasms |
| 5 | Palliative Care |
| 5 | Oceanic Ancestry Group |
| 5 | Observational Studies as Topic |
| 5 | Nutrition Assessment |
| 5 | North America |
| 5 | Netherlands |
| 5 | Nerve Tissue Proteins |
| 5 | Neoplasm, Residual |
| 5 | Mice, Transgenic |
| 5 | Lupus Erythematosus, Systemic |
| 5 | Lung |
| 5 | Lipids |
| 5 | Life Style |
| 5 | Leukemia, Myeloid, Acute |
| 5 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
| 5 | Kidney Neoplasms |
| 5 | Insulin-Like Growth Factor I |
| 5 | In Situ Hybridization, Fluorescence |
| 5 | Hemorrhage |
| 5 | Heart Valve Prosthesis |
| 5 | Gout |
| 5 | Geography |
| 5 | Genomic Imprinting |
| 5 | Genome |
| 5 | Genome, Bacterial |
| 5 | Genetic Linkage |
| 5 | Gene-Environment Interaction |
| 5 | Gene Regulatory Networks |
| 5 | Fusion Proteins, bcr-abl |
| 5 | Exercise Test |
| 5 | Equipment Design |
| 5 | Environment |
| 5 | Endometrial Neoplasms |
| 5 | Electroencephalography |
| 5 | Electrocardiography |
| 5 | Drosophila melanogaster |
| 5 | Disease Outbreaks |
| 5 | Diabetes Mellitus |
| 5 | Diabetes Mellitus, Type 1 |
| 5 | Dexamethasone |
| 5 | Dacarbazine |
| 5 | DNA, Mitochondrial |
| 5 | Cyclophosphamide |
| 5 | Crohn Disease |
| 5 | Critical Illness |
| 5 | Congresses as Topic |
| 5 | Chronic Disease |
| 5 | Cholesterol, HDL |
| 5 | Cardiology |
| 5 | Carcinoma, Renal Cell |
| 5 | Calcium |
| 5 | C-Reactive Protein |
| 5 | Bortezomib |
| 5 | Body Height |
| 5 | Birds |
| 5 | Atmosphere |
| 5 | Asia |
| 5 | Apoptosis |
| 5 | Aortic Valve |
| 5 | Aortic Valve Stenosis |
| 5 | Antirheumatic Agents |
| 5 | Antigens, CD |
| 5 | Antifungal Agents |
| 5 | Anemia |
| 5 | Alcohol Drinking |
| 4 | X-Ray Diffraction |
| 4 | World Health Organization |
| 4 | Waist Circumference |
| 4 | Vitamin D |
| 4 | Tumor Necrosis Factor-alpha |
| 4 | Tissue Plasminogen Activator |
| 4 | Tidal Volume |
| 4 | Thrombolytic Therapy |
| 4 | Telomere Homeostasis |
| 4 | Stress, Psychological |
| 4 | Stress, Physiological |
| 4 | Statistics as Topic |
| 4 | Sirolimus |
| 4 | Sequence Homology, Amino Acid |
| 4 | Sequence Analysis, RNA |
| 4 | Respiratory Function Tests |
| 4 | Research |
| 4 | Renal Dialysis |
| 4 | Rare Diseases |
| 4 | Radiopharmaceuticals |
| 4 | Quality-Adjusted Life Years |
| 4 | Proto-Oncogene Proteins |
| 4 | Proteomics |
| 4 | Prostheses and Implants |
| 4 | Prions |
| 4 | Pregnancy Complications |
| 4 | Plant Stems |
| 4 | Plant Physiological Phenomena |
| 4 | Piperidines |
| 4 | Phosphorylation |
